Early detection and intervention of psychosis. A review

References

• Knapp MRJ, Almond S, Percudani M. Costs of schizophrenia, a review. Schizophrenia, M May, N Sartorius. John Wiley & Sons, Chichester 1999; 407–54
   Google Scholar
• Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2003; 30: 279–93
   Web of Science ®Google Scholar
• Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001; 179: 498–502
   PubMed Web of Science ®Google Scholar
• Kelly C, McCreadie RG, MacEwan T, Carey S. Nithsdale schizophrenia surveys. 17. Fifteen year review. Br J Psychiatry 1998; 172: 513–7
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Crow TJ, Johnson AL, Macmillan JF. The Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. Br J Psychiatry 1986; 148: 115–20
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K, Löffler W, Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162: 80–6
   PubMed Web of Science ®Google Scholar
• Larsen TK, Johannessen JO, Opjordsmoen S. First-episode schizophrenia with long duration of untreated psychosis. Br J Psychiatry 1998; 172 Suppl 33: 45–52
   Web of Science ®Google Scholar
• Häfner H, Löffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiat Scand 1999; 100: 105–18
   PubMed Web of Science ®Google Scholar
• Davidson M, Reichenberg A, Rabinpwitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999; 156: 1328–35
   PubMed Web of Science ®Google Scholar
• Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148: 120–7
   PubMed Web of Science ®Google Scholar
• Helgason L. Twenty years’ follow up of first psychiatric presentation for schizophrenia: What could have been prevented?. Acta Psychiatr Scand 1990; 81: 231–5
   PubMed Web of Science ®Google Scholar
• Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first episode schizophrenia. Am J Psychiatry 1992; 149: 1183–8
   PubMed Web of Science ®Google Scholar
• Edwards J, Maude D, McGorry PD, Harrigan SM, Cocks JT. Prolonged recovery in first-episode psychosis. Br J Psychiatry Suppl 1998; 172: 107–16
   PubMedGoogle Scholar
• Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry 2005; 62: 975–83
   PubMed Web of Science ®Google Scholar
• Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry 2005;162:1785–804. Review.
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull 2003; 29: 757–69
   PubMed Web of Science ®Google Scholar
• Lappin JM, Morgan K, Morgan C, Hutchison G, Chitnis X, Suckling J, et al. Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res 2006; 83: 145–53
   PubMed Web of Science ®Google Scholar
• Parnas J. From predisposition to psychosis: Progression of symptoms in schizophrenia. Acta Psychiatr Scand ;99 Suppl 1999; 395: 20–9
   Google Scholar
• Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962; 17: 827–38
   Web of Science ®Google Scholar
• Bleuler E :Dementia Praecox oder die Gruppe der Schizophrenien. Translation Dementia Praecox or the group of schizophrenias. New York: International University Press; 1911/1950.
   Google Scholar
• Yung AR, McGorry PD. The prodromal phase of first episode psychosis: Past and current conceptualizations. Schizophr Bull 1996; 22: 353–70
   PubMed Web of Science ®Google Scholar
• McGorry PD, Singh BS. Schizophrenia: Risk and possibility. Handbook of preventive psychiatry, B Raphael, GD Burrows. Elsevier, New York 1995; 492–514
   Google Scholar
• Gottesman II. Schizophrenia genesis: The origin of madness. Freeman, New York 1991
   Google Scholar
• Kendler KS, Diehl SR. The genetics of schizophrenia: A current, genetic–epidemiologic perspective. Schizophr Bull 1993;19:261–85. Review.
   PubMed Web of Science ®Google Scholar
• Asherson P, Mant R, McGuffin P. Genetics and schizophrenia. Schizophrenia, ST Hirsh, DR Weinberger. Blackwell Science, Cambridge 1995; 253–74
   Google Scholar
• Gottesman II. Schizophrenia epigenesis: Past, present, and future. Acta Psych Scand 1994; 90: 26–33
   Web of Science ®Google Scholar
• Tienari P, Wynne LC, Moring J, Lahti I, Naarala M, Sorri A, et al. The Finnish adoptive family study of schizophrenia. Implications for family research. Br J Psychiatry 1994; 23 Suppl: 20–6
   Google Scholar
• Siira V, Wahlberg KE, Miettunen J, Tienari P, Laksy K. Differentiation of adoptees at high versus low genetic risk for schizophrenia by adjusted MMPI indices. Eur Psychiatry 2006; 21: 245–50
   PubMed Web of Science ®Google Scholar
• Olin SS, John RS, Mednick SA. Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: A ROC analysis. Schizophr Res 1995; 16: 53–66
   PubMed Web of Science ®Google Scholar
• Olin SS, Mednick SA, Cannon T, Jacobsen B, Parnas J, Schulsinger F, et al. School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry 1998; 172 Suppl 33: 7–13
   Web of Science ®Google Scholar
• Owens DG, Miller P, Lawrie SM, Johnstone EC. Pathogenesis of schizophrenia: A psychopathological perspective. Br J Psychiatry 2005; 186: 386–93
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia: Findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005; 186: 18–25
   PubMed Web of Science ®Google Scholar
• Owens DG, Johnstone EC. Precursors and prodromata of schizophrenia: Findings from the Edinburgh High Risk Study and their literature context. Psychol Med. 2006; 36: 1501–14
   PubMed Web of Science ®Google Scholar
• Glatt SJ, Stone WS, Faraone SV, Seidman LJ, Tsuang MT. Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br J Psychiatry 2006; 189: 337–45
   PubMed Web of Science ®Google Scholar
• Jones P, Rodgers B, Murray R, Marmot MG. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1946; 344: 1398–402
   Google Scholar
• Jones PB, van Os JJ. Predicting schizophrenia in teenagers: Pessimistic results from the British 1946 birth cohort. Abstract of the 7th International Congress on Schizophrenia Research, Colorado Springs; 1997. p. 11.
   Google Scholar
• Salokangas RKR. Precursors and markers of psychosis—Scientific basis for examinations and intervention. Neurol Psychiat Brain Res 2001; 9: 105–26
   Google Scholar
• Hultman CM, Sparen P, Takei N, Murray RM, Cnattingius S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: Case–control study. BMJ 1999; 318: 421–6
   PubMed Web of Science ®Google Scholar
• Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M. Obstetric complications and the risk of schizophrenia: A longitudinal study of a national birth cohort. Arch Gen Psychiatry 1999; 56: 234–40
   PubMed Web of Science ®Google Scholar
• van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: An urban–rural comparison. Arch Gen Psychiatry 2001; 58: 663–8
   PubMed Web of Science ®Google Scholar
• van Os J, Pedersen CB, Mortensen PB. Confirmation of synergy between urbanicity ja familial liability in the causation of psychosis. Am J Psychiatry 2004; 161: 2312–4
   PubMed Web of Science ®Google Scholar
• Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, Murray RM, Jones PB. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Arch Gen Psychiatry 2006; 63: 250–8
   PubMed Web of Science ®Google Scholar
• Selten JP, Veen N, Feller W, Blom JD, Schols D, Camoenie W, et al. Incidence of psychotic disorders in immigrant groups to The Netherlands. Br J Psychiatry 2001; 178: 367–72
   PubMed Web of Science ®Google Scholar
• Hjern A, Wicks S, Dalman C. Social adversity contributes to high morbidity in psychoses in immigrants—A national cohort study in two generations of Swedish residents. Psychol Med 2004; 34: 1025–33
   PubMed Web of Science ®Google Scholar
• Kirkbridge JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Arch Gen Psychiatry 2006; 63: 250–8
   PubMed Web of Science ®Google Scholar
• Leao TS, Sundquist J, Frank G, Johansson LM, Johansson SE, Sundquist K. Incidence of schizophrenia or other psychoses in first- and second-generation immigrants: A national cohort study. J Nerv Ment Dis 2006; 194: 27–33
   PubMed Web of Science ®Google Scholar
• Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: A meta-analysis. Br J Psychiatry 1995; 167: 786–93
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, et al. Early detection and secondary prevention of psychosis: Facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254: 117–28
   PubMed Web of Science ®Google Scholar
• Mäki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, et al. Predictors of schizophrenia—A review. Br Med Bull 2005; 73–74: 1–15
   PubMed Web of Science ®Google Scholar
• Yung Y, Phillips LJ, Cotton S, Yung AR, Francey SM, Yuen HP, et al. Obstetric complications and transition to psychosis in an “ultra” high risk sample. Aust N Z J Psychiatry 2005; 39: 460–6
   PubMed Web of Science ®Google Scholar
• Jones PB, Done DJ. From birth to onset: A developmental perspective of schizophrenia in two national birth cohorts. Neurodevelopment and adult psychopathology, MS Keshavan, RM Murray. Cambridge University Press, Cambridge 1997; 119–36
   Google Scholar
• Cannon M, Jones P, Huttunen MO, Tanskanen A, Huttunen T, Rabe-Hesketh S, et al. School performance in Finnish children and later development of schizophrenia: A population-based longitudinal study. Arch Gen Psychiatry 1999; 56: 457–63
   PubMed Web of Science ®Google Scholar
• Rantakallio P, Jones P, Moring J, von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: A 28-year follow-up. Int J Epidemiology 1997; 26: 837–43
   PubMed Web of Science ®Google Scholar
• David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: A population-based cohort study. Psychol Med 1997; 27: 1311–23
   PubMed Web of Science ®Google Scholar
• Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br J Psychiatry 2002; 181: 298–305
   PubMed Web of Science ®Google Scholar
• Beiser M, Erickson D, Fleming JAE, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349–54
   PubMed Web of Science ®Google Scholar
• Meehl PE. Toward an integrated theory of schizotaxia, schizotypy and schizophrenia. J Pers Dis 1990; 4: 1–99
   Google Scholar
• Hoch PH, Cattel JP, Strahl MO, Pennes HH. The course and outcome of pseudoneurotic schizophrenia. Am J Psychiatry 1962; 119: 106–15
   PubMed Web of Science ®Google Scholar
• Salokangas RKR. Skitsofreniaan sairastuneiden psykososiaalinen kehitys. (The psychosocial development of schizophrenic patients.) Kansaneläkelaitoksen julkaisuja AL 7, Turku; 1977.
   Google Scholar
• Salokangas RKR. Skitsofrenian hoito ja ennuste. (Treatment and outcome in schizophrenia.) Kansanterveystieteen julkaisuja M 89/85. Tampereen yliopiston kansanterveystieteen laitos, Turun yliopiston Psykiatrian klinikka, Tampere; 1985.
   Google Scholar
• Nordentoft M, Thorup A, Petersen L, Öhlenschlaeger J, Malau M, Östergaard C, et al. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res 2006; 82: 29–40
   Google Scholar
• Lewis G, David AS, Malmberg A, Allebeck P. Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry 2000; 177: 416–20
   PubMed Web of Science ®Google Scholar
• Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, et al. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry 2001; 58: 959–64
   PubMed Web of Science ®Google Scholar
• Reihenberg A, Goldenberg J. Self-reported mentl health difficulties and subsequent risk for schizophrenia in females: A 5-year follow-up cohort study. Schizophr Res 2006; 82: 233–9
   PubMed Web of Science ®Google Scholar
• Salokangas RKR. Psychosocial prognosis in schizophrenia. Formation of the prognosis for schizophrenic patients: A multivariate analysis. Annales Univ Turkuensis Ser. D 9, Turku; 1978.
   Google Scholar
• Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmiedtke A, et al. IRAOS: An instrument for the assessment of onset of early course of schizophrenia. Schizophr Res 1992; 6: 209–23
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K. Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to the first admission. Negative versus positive schizophrenia, A Marneros, NC Andreasen, MT Tsuan. Springer, Berlin 1991; 134–59
   Google Scholar
• Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: Challenging the paradigm of two separate diseases—A controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77: 11–24
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K. Early detection of schizophrenia. Current evidence and future perspectives. World Psychiatry 2006; 5: 130–8
   PubMed Web of Science ®Google Scholar
• Chapman JP. The early symptoms of schizophrenia. Br J Psychiatry 1966; 112: 225–51
   PubMed Web of Science ®Google Scholar
• Kapur S. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160: 13–23
   PubMed Web of Science ®Google Scholar
• Selten JP, Cantor-Graae E. Social defeat: Risk factor for schizophrenia?. Br J Psychiatry 2005; 187: 101–2
   PubMed Web of Science ®Google Scholar
• McGorry PD, McFarlane C, Patton GC, Bell R, Hibbert ME, Jackson H, et al. The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey. Acta Psychiatr Scand 1995; 92: 241–9
   PubMed Web of Science ®Google Scholar
• Hanssen MS, Bijl RV, Vollebergh W, van Os J. Self-reported psychotic experiences in the general population: A valid screening tool for DSM-III-R psychotic disorders?. Acta Psychiatr Scand 2003; 107: 369–77
   PubMed Web of Science ®Google Scholar
• Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry 2000; 57: 1053–8
   PubMed Web of Science ®Google Scholar
• Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Ach Gen Psychiatry 2002; 59: 449–56
   PubMed Web of Science ®Google Scholar
• Rössler W, Riecher-Rössler A, Angst J, Murray R, Gamma A, Eich D, et al. Psychotic experiences in the general population: A twenty-year prospective community study. Schizophr Res 2007; 92: 1–14
   PubMed Web of Science ®Google Scholar
• van Os J, Verdoux H, Maurice-Tison S, Gay B, Liraud F, Salamon R, et al. Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 459–63
   PubMed Web of Science ®Google Scholar
• Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits?. Eur Arch Psychiatry Clin Neurosci 1995; 246: 17–28
   PubMed Web of Science ®Google Scholar
• Häfner H, an der Heiden W. Course and outcome of schizophrenia. Schizophrenia2nd edition, SR Hirsch, DR Weinberger. Blackwell, London 2003; 101–41
   Google Scholar
• Jablensky A. The epidemiological horizon. Schizophrenia2nd edition, SR Hirsch, DR Weinberger. Blackwell, London 2003; 203–31
   Google Scholar
• Goldberg T, David A, Gold JM. Neurocognitive deficits in schizophrenia. Schizophrenia2nd edition, SR Hirsch, DR Weinberger. Blackwell, London 2003; 168–84
   Google Scholar
• Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr Bull 1996; 22: 257–69
   PubMed Web of Science ®Google Scholar
• MacEwan TH, Athawes RWB. The nithsdale schixophrenia surveys XV. Social adjustment in schizophrenia: Associations with gender, symptoms and childhood antecedents. Acta Psychiatry Scand 1997; 95: 254–58
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Miller TJ, Woods SW, Hoffman RE, Davidson L. Instrument for the assessment of prodromal symptoms and states. Early intervention in psychotic disorders, T Miller, SA Mednick, TH McGlashan, J Libiger, JO Johannessen. Kluwer Academic, Dordrecht 2001; 135–49
   Google Scholar
• Salokangas RKR, Heinimaa M, Huttunen J, Klosterkötter J, Ruhrmann S, von Reventlow H, et al. Quality of life in psychiatric patients vulnerable to psychosis. Results of the EPOS study. Presentaion in the 14th AEP Congress 4–8 March, 2006, Nice. Eur Psychiatry 2006;21 Suppl 1:S58.
   Google Scholar
• Yung AR, Buckby JA, Cotton SM, Cosgrave EM, Killackey EJ, Stanford C, et al. Psychotic-like experiences in nonpsychotic help-seekers: Associations with distress, depression, and disability. Schizophr Bull 2006; 32: 352–9
   PubMed Web of Science ®Google Scholar
• Amminger GP, Leicester S, Yung AR, Phillips LJ, Berger GE, Francey SM, et al. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res 2006; 84: 67–76
   PubMed Web of Science ®Google Scholar
• Woods S Effects of Olanzapine in those at high risk of psychosis. Presentation in an international conference, “The early phase of psychosis—Research and treatment”, 3–4 April, 2006, London.
   Google Scholar
• Goldberg TE, Gold JM. Neurocognitive deficits in schizophrenia. Schizophrenia, SR Hirsch, DR Weinberger. Blackwell Science, Cambridge 1995; 146–62
   Google Scholar
• Lawrie SM. The neuropsychology of schizophrenia. In: Johnstone ED, Humphreys MS, Lang FH, Lawrie SM, Sandler R. Schizophrenia. Concepts and clinical management. Cambridge: Cambridge University Press; 1999. p. 129–44.
   Google Scholar
• Roitman SE, Cornblatt BA, Bergman A, Obuchowski M, Mitropoulou V, Keefe RS, et al. Attentional functioning in schizotypal personality disorder. Am J Psychiatry 1997;154:655–60. Published erratum appears in Am J Psychiatry 1997;154:1180.
   PubMed Web of Science ®Google Scholar
• Franke P, Maier W, Hain C, Klingler T. Wisconsin Card Sorting Test: An indicator of vulnerability to schizophrenia?. Schizophr Res 1992; 6: 243–9
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Keilp JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994; 20: 31–46
   PubMed Web of Science ®Google Scholar
• Bryne M, Hodges A, Grant E, Johnstone EC. Evidence for executive dysfunction in young people at high genetic risk for schizophrenia? Results of the Hayling Sentence Completion Test. Schitzophr Res 1998a; 29: 43
   Web of Science ®Google Scholar
• Toulopoulou T, Morris RG, Murray RM. Spatial working memory and strategy formation in schizophrenic patients and their first degree relatives. Schitzophr Res 1998; 29: 138
   Web of Science ®Google Scholar
• Cannon TD, van Erp TGM, Finklestein JRJ, Huttunen M, Kaprio J, Lönnqvist J, et al. Disturbance in a frontal lobe-working memory circuit as an inherited neurobiological substrate in schizophrenia: Results from a controlled twin study. Schizophr Res 1999; 36: 88
   Web of Science ®Google Scholar
• Byrne M, Hodges A, Grant E, Owens DC, Johnstone EC. Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: Preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med 1999; 29: 1161–73
   PubMed Web of Science ®Google Scholar
• Finklestein JRJ, Cannon TD, Huttunen T, Tuulio-Henrikson A, Kaprio J, Lönnqvist J, et al. The viability of attention deficit as markers of genetic vulnerability to schizophrenia: A discordant twin study. Schizophr Res 1999; 36: 90
   Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Gscheidle T, Bigelow L, Weinberger DR. Hereditability estimates for independent domains of cognitive dysfunction in schizophrenia. Schizophr Res 2000; 41: 89–90
   Web of Science ®Google Scholar
• Trandafir A, Meary A, Schurhoff F, Leboyer M, Szoke A. Memory tests in first-degree adult relatives of schizophrenic patients: A meta-analysis. Schizophr Res 2006; 81: 217–26
   PubMed Web of Science ®Google Scholar
• Cornblatt B. High-risk research: Implications for new interventions. Plenary presentation, International Congress on Schizophrenia Research, 21 April, 1999.
   Google Scholar
• Meurice EE. Rorschach “Schizophrenia” Signs in healthy first degree family members of patients with schizophrenia. A study of three complete families. Schitzophr Res 1998; 29: 59–60
   Web of Science ®Google Scholar
• Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess 2003; 80: 50–7
   PubMed Web of Science ®Google Scholar
• Ilonen T. Is it possible to differentiate patients vulnerable to psychosis? Presentation at the XVIII International Congress of Rorschach and Projective Methods, 25–30 July, 2005, Barcelona. Abstracts. p. 333.
   Google Scholar
• Klosterkötter J, Schultze-Lutter F, Steinmeyer EM, Wieneke A. Are self-experienced neuropsychological deficits able to indicate liability to schizophrenia? Results of a comparative study of 1st-degree relatives of schizophrenics. Schitzophr Res 1998; 29: 64
   Web of Science ®Google Scholar
• Schulze-Lutter F. Basic symptoms. Presentation in an international conference, “The early phase of psychosis—Research and treatment”, 3–4 April, 2006, London.
   Google Scholar
• Bartok E, Berecz R, Glaub T, Degrell I. Cognitive functions in prepsychotic patients. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 621–5
   PubMed Web of Science ®Google Scholar
• Tabraham P, Brett C, Johns L, Valmaggia L, Broome M, Woolley J, et al. Spatiel working memory is impaired in individuals at high risk for psychosis. Schizopr Res 2006; 81 Suppl:271.
   Google Scholar
• Pflueger MO, Gschwandtner U, Aston J, Borgwardt S, Stieglitz RD. The neuropsychological assessment of the risk for psychosis in the Basel FEPSY study. Eur Psychiatry 2006; 21 Suppl 1: S48
   Google Scholar
• Brewer W, Francey S, Yung A, Velakoulis D, Anderson V, McGorry P, et al. Cognitive and olfactory deficits: Course from high risk to first-episode psychosis. Schitzophr Res 1998; 29: 54–5
   Web of Science ®Google Scholar
• Brewer W, Francey S, Yung A, Velakoulis D, Anderson V, McGorry P, et al. Cognitive and related olfactory deficits in young people at high risk for psychosis. Abstract of the 7th International Congress on Schizophrenia Research. Schizophr Res 1999; 36: 125
   Google Scholar
• Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry 2003; 160: 1790–4
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: A neurodevelopment perspective. Schizophr Bull 2003; 29: 633–51
   PubMed Web of Science ®Google Scholar
• Smith CW, Park S, Cornblatt B. Spatial working memory deficits in adolescents at clinical high risk for schizophrenia. Schizophr Res 2006; 81: 211–5
   PubMed Web of Science ®Google Scholar
• Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, et al. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 2006; 84: 100–11
   PubMed Web of Science ®Google Scholar
• Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophr Res 2005; 79: 127–36
   PubMed Web of Science ®Google Scholar
• Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull 2003; 29: 831–43
   PubMed Web of Science ®Google Scholar
• Whyte MC, Brett C, Harrison LK, Byrne M, Miller P, Lawrie SM, et al. Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry 2006; 59: 730–9
   PubMed Web of Science ®Google Scholar
• Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005; 162: 71–8
   PubMed Web of Science ®Google Scholar
• Pantelis C. Neuropsychological impairments in the At Risk Mental State. Presentation in an international conference, “The early phase of psychosis—Research and treatment”, 3–4 April, 2006, London
   Google Scholar
• Andreasson S, Allbeck P, Engström A, Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–86
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry 2004; 184: 110–17
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11
   PubMed Web of Science ®Google Scholar
• Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005; 57: 1117–27
   PubMed Web of Science ®Google Scholar
• Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996; 40: 1155–63
   PubMed Web of Science ®Google Scholar
• Huber G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr. Neurol Psychiatry 1966; 34: 409–26
   Google Scholar
• Huber G. Verlaufsprobleme schizophrenen Erkrankungen. Schweiz Arch Neurol Neurochir Psychiatry 1968; 101: 346–68
   PubMedGoogle Scholar
• Huber G, Gross G, Schüttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980; 6: 592–605
   PubMed Web of Science ®Google Scholar
• Gross G, Huber G. Prodromes and primary prevention of schizophrenic psychoses. Neurol Psychiatry Brain Res 1998; 6: 51–8
   Google Scholar
• Gross G, Huber G, Klosterkötter J, Linz M. BSABS Bonner Skala für die Beurtailung von Basissymptomen (Bonn Scale for the Assessment of Basic Symptoms). Springer, Manual, Kommentar, Dokumentationbogen. Berlin 1987
   Google Scholar
• Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158–64
   PubMed Web of Science ®Google Scholar
• Bechdolf A, Wagner M, Veith V, Pukrop R, Berning J, Stamm E, et al. A randomized controlled trail of cognitive–behavioral therapy in the early initial prodromal state of psychosis. Presentation in the 18th Biennial Winter Workshop on Schizophrenia Research, Davos, 4 February 2006. Schizophr Res 2006; 81 Suppl:22–3.
   Google Scholar
• Comprehensive Assessment of At Risk Mental States (CAARMS) Version 2, February, 1996.
   Google Scholar
• Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis: A step towards indicated prevention of schizophrenia. Br J Psyschiatry 1998; 172 Suppl 33: 14–20
   Web of Science ®Google Scholar
• Yung AR, Jackson HJ. The onset of psychotic disorder: Clinical and research aspects. The recognition and management of early psychosis. A preventive approach, PD McGorry, HJ Jackson. Cambridge University Press, Cambridge 1999; 27–50
   Google Scholar
• Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006; 84: 57–66
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Aust NZ J Psychiatry 2005; 39: 964–71
   PubMed Web of Science ®Google Scholar
• Miller TJ, McGlashan TH, Lifshey Rosen J, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 159: 863–65
   PubMed Web of Science ®Google Scholar
• Miller TI, McGlashan TH, Woods SW, Stein K, Driesen N, Concran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiat Q 1999; 70: 273–87
   PubMed Web of Science ®Google Scholar
• Woods S. SIPS, SOPS & COPS. Presentation in an international conference, “The early phase of psychosis—Research and treatment”, 3–4 April, 2006, London.
   Google Scholar
• Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703–15
   PubMed Web of Science ®Google Scholar
• Phillips LJ, Yung A, McGorry PD. Identification of young people at risk of psychosis: Validation of the Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Zeal J Psychiatry 2000;34 Suppl:164–9.
   PubMedGoogle Scholar
• Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophr Res 2004; 67: 131–42
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Ach Gen Psychiatry 2002; 59: 921–28
   PubMed Web of Science ®Google Scholar
• Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Randomised controlled trial. Br J Psychiatry 2004; 185: 291–7
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins DO, Addington J, Woods SW, Miller TJ, et al. Olanzapine vs. placebo for prodromal schizophrenia. Schizophr Res 2004;67 Suppl:6.
   PubMedGoogle Scholar
• Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with “at-risk mental states”. Schizophr Res 2004; 71: 227–37
   PubMed Web of Science ®Google Scholar
• Broome RM, Woolley JB, Johns LC, Valmaggia LR, Tabraham P, Gafoor R, et al. Outreach and support in south London (OASIS): Implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry 2005;20:372–78. Follow-up at a maximum catamnestic interval of 30 months.
   PubMed Web of Science ®Google Scholar
• McGlashan TH. Early detection and intervention of schizophrenia: Rationale and research. Br J Psychiatry 1998; 172 Suppl 33: 3–6
   Web of Science ®Google Scholar
• Jablensky A. Prevalence and incidence of schizophrenia spectrum disorders: Implications for prevention. ANZ J Psychiatry 2000; 34(Suppl)S26–S34
   Google Scholar
• McGrath J. Universal interventions for primary prevention of schizophrenia. Aust NZ J Psychiatry 2000; 34(Suppl)S58–S64
   Google Scholar
• Warner R. The prevention of schizophrenia: What interventions are safe and effective?. Schizophr Bull 2001; 27: 551–62
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Malaspina D, Susser E. The concept of population prevention: Application to schizophrenia. Schizophr Bull 2003; 29: 791–801
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins DO, Addington J, Miller TJ, Woods SW, et al. Randomized, double-blind trial of Olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790–9
   PubMed Web of Science ®Google Scholar
• Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 2003; 54: 453–64
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Schulze-Lutter F, Maier W, Klosterkötter J. Pharmacological intervention in the initial prodromal phase of psychosis. Eur Psychiatr 2005; 20: 1–6
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Hoppmann B, Theyshn S, Picker H, Kühn K-U, Schulze-Lutter F, et al. Acute symptomatic treatment clinically at risk for psychosis. Schizophr Res 2006; 86: S8
   Web of Science ®Google Scholar
• Keri S, Kelemen O, Janka Z. Therapy of mental states at high risk for psychosis: Preliminary results from Hungary (in Hungarian) Orv Hetil 2006; 147: 201–4
   PubMedGoogle Scholar
• Walsh BC, Tully E, Thomas L, McGlashan TH, Woods S. Aripiprazole treatment of the psychosis prodrome. Schizophr Res 2006; 86: S7
   Web of Science ®Google Scholar
• Tsuang MT, Stone WS, Tarbox SI, Faraone SV. An integration of schizophrenia with schizotypy: Identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res 2002; 54: 169–75
   PubMed Web of Science ®Google Scholar
• Chong SA, Verma SK, McGorry P. Psychosis—A need for preemptive intervention?. Singapore Med J 2003; 44: 426–7
   PubMedGoogle Scholar
• Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry 2004; 185: 291–7
   PubMed Web of Science ®Google Scholar
• Bechdolf A, Wagner M, Veith V, Ruhrman S, Janssen B, Bottlender R, et al. A randomized controlled multicentre trial of cognitive behavioral therapy in the early initial prodromal state of psychosis. Schizophr Res 2006; 86: S8
   Google Scholar
• Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, et al. Early detection and secondary prevention of psychosis: Facts and visions. Eur Arch Psychiatry Clin Neurosci 2004;254:117–28. Review.
   PubMed Web of Science ®Google Scholar